ROG 71.02 Rogers Corp $ROG Hit a 52 week high of 71.48

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ROG 71.02 Rogers Corp $ROG Hit a 52 week high of 71.48 Closing the day 11/10/14 at 71.02 -0.05 -0.07% With a day low of 70.44 and a total volume of 57,569.

ROG Recent Posts: http://investorshangout.com/Rogers-Corp-ROG-52545/

ROG Rogers Corp Recent Headline News

Plug Power Names Paul B. Middleton as New Chief Financial Officer
GlobeNewswire - Mon Nov 10, 3:11PM CST
Plug Power Inc. (Nasdaq LUG), a leader in providing clean, reliable energy products, announces today that Paul B. Middleton, CPA, has been appointed as the company's new Chief Financial Officer (CFO). Middleton has a proven background in strategy, mergers and acquisitions, controls and risk management for manufacturing and technology companies, and is expected to bring strong leadership in financial management to Plug Power.
PLUG: 5.28 (-0.02), ROG: 71.02 (-0.05)

Uptrend Call Working As Rogers Stock Rises 27.3% (ROG)
Comtex SmarTrend(R) - Fri Nov 07, 9:53AM CST
SmarTrend identified an Uptrend for Rogers (NYSE:ROG) on October 16th, 2014 at $55.50. In approximately 3 weeks, Rogers has returned 27.25% as of today's recent price of $70.62.
ROG: 71.02 (-0.05)

Is Rogers Corporation (ROG) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:35AM CST
Rogers Corporation is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
ROG: 71.02 (-0.05)

Rogers Corporation to Participate in Baird's 2014 Industrial Conference
Business Wire - Tue Nov 04, 7:15AM CST
Rogers Corporation (NYSE:ROG) will be participating in the Baird's 2014 Industrial Conference on Tuesday, November 11, 2014 at the Four Seasons Hotel in Chicago, IL.
ROG: 71.02 (-0.05)

NYSE stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
DHX: 10.94 (+0.41), CALX: 11.38 (-0.06), EGL: 43.67 (+0.20), V: 250.21 (-2.22), OCN: 21.96 (+0.79), GNC: 43.05 (-0.01), ROG: 71.02 (-0.05), DRL: 5.13 (-0.37), ACCO: 8.85 (+0.30), CEB: 74.82 (+0.99), FLTX: 36.80 (-0.23)

Rogers Corporation's (ROG) CEO Bruce Hoechner on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 2:43PM CDT

ROG: 71.02 (-0.05)

Peter C. Wallace Elected Chairman of Applied Industrial Technologies Board of Directors
PR Newswire - Wed Oct 29, 5:31AM CDT
The Board of Directors of Applied Industrial Technologies (NYSE: AIT) has elected Peter C. Wallace as its independent Chairman. He succeeds John F. Meier, who has served as Chairman since 2011 and who will continue to serve as a member of the Board.
ROG: 71.02 (-0.05), AIT: 49.40 (+0.07)

Rogers beats by $0.37, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:16PM CDT

ROG: 71.02 (-0.05)

Rogers Corp. posts 3Q profit
Automated Insights - Tue Oct 28, 3:58PM CDT
ROGERS, Conn. (AP) _ Rogers Corp. (ROG) on Tuesday reported earnings of $20.4 million, or $1.09 per share, in its third quarter.
ROG: 71.02 (-0.05)

Rogers Corporation Reports All-Time Record Quarterly Sales for the Third Quarter of 2014
Business Wire - Tue Oct 28, 3:01PM CDT
--Earnings per diluted share of $1.09
ROG: 71.02 (-0.05)

Rogers Corporation Invites You to Join its Third Quarter 2014 Conference Call
Business Wire - Tue Oct 21, 7:27AM CDT
Rogers Corporation (NYSE: ROG) plans to release results for its 2014 third quarter after the close of trading on Tuesday, October 28, 2014. A copy of the announcement will be available on the Rogers website at www.rogerscorp.com/news.
ROG: 71.02 (-0.05)

NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors
GlobeNewswire - Mon Oct 20, 6:00AM CDT
NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on discovering, developing, and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, announced today that they have entered into an exclusive worldwide license agreement with Genentech, a member of the Roche Group (SIX:RO) (SIX:ROG) (OTCQX:RHHBY), for the development of NLG919, NewLink's IDO pathway inhibitor. The parties also entered into a research collaboration for the discovery of next generation IDO/TDO compounds.
NLNK: 34.40 (+2.25), ROG: 71.02 (-0.05)

Rogers names Helene Simonet to its board as director
M2 - Wed Oct 15, 6:57AM CDT
Rogers Corporation (NYSE:ROG), a high-performance engineered materials solutions company, announced on Wednesday that Helene Simonet has been appointed to its board of directors, filling the vacancy left by a recently retired director.
ROG: 71.02 (-0.05), COHR: 58.41 (-0.04)

Shares of ROG Down 16.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 14, 5:06PM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 3 months, Rogers has returned 16.14% as of today's recent price of $53.40.
ROG: 71.02 (-0.05)

Rogers Corporation Appoints Helene Simonet to Its Board of Directors
Business Wire - Tue Oct 14, 3:00PM CDT
Rogers Corporation (NYSE: ROG) today announced that its Board of Directors has appointed Helene Simonet to serve as a member of the Company's Board. This addition fills a vacancy on the Board due to a recent director retirement. Ms. Simonet will be a member of the Audit Committee.
ROG: 71.02 (-0.05), COHR: 58.41 (-0.04)

Rogers Shares Down 15.4% Since SmarTrend's Sell Call (ROG)
Comtex SmarTrend(R) - Tue Oct 07, 11:08AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 3 months, Rogers has returned 15.37% as of today's recent price of $53.89.
ROG: 71.02 (-0.05)

Industry Leaders Form the RF Energy Alliance to Facilitate the Adoption of Solid-State RF Energy Technology
Business Wire - Mon Oct 06, 9:00AM CDT
Industry leaders, including E.G.O. Elektro-Geratebau GmbH, Huber+Suhner, ITW, NXP Semiconductors, Rogers Corporation and Whirlpool R&D (an affiliate company of Whirlpool Corporation), today announced the formation of the RF Energy Alliance. This consortium intends to advance today's power and heating solutions by equipping engineers and designers with a transformative, cost-effective and highly efficient heating and power source--solid-state radio frequency (RF) energy. To achieve this, the Alliance will drive the development of standards, education and promotion of solid-state RF energy.
WHR: 173.79 (-2.02), ROG: 71.02 (-0.05)

14.4% Return Seen to Date on SmarTrend Rogers Call (ROG)
Comtex SmarTrend(R) - Tue Sep 30, 9:44AM CDT
SmarTrend identified a Downtrend for Rogers (NYSE:ROG) on July 18th, 2014 at $63.68. In approximately 2 months, Rogers has returned 14.43% as of today's recent price of $54.49.
ROG: 71.02 (-0.05)

Rogers Corp. (ROG) Stock Research Links

ROG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading